Media
News & Events
Asceneuron to attend the 38th Annual J.P. Morgan Healthcare Conference
Asceneuron to attend the 38th Annual J.P. Morgan Healthcare Conference taking place January 13-16, 2020 at the Westin St. Francis in San Francisco, CA.
Asceneuron at Genesis 2019
Asceneuron will participate in the Meeting Biotech Rising Star session, being held on December 11th at Genesis 2019, London.
“A bright future for CNS and Alzheimer’s?”
Read the interview of our CEO Dirk Beher in Pharmaphorum.
Asceneuron appoints Dr Eric Yuen to the Board of Directors
Asceneuron appoints experienced CNS clinician Dr Eric Yuen to the Board of Directors
Asceneuron proudly sponsors Atypical Parkinsonian Syndromes Workshop
As part of its commitment to neurodegenerative disease research and development, Asceneuron proudly sponsors the Atypical Parkinsonian Syndromes Workshop organised by the International Parkinson and Movement Disorder Society (MDS) in May 17-18, 2019 in Munich, Germany.
Asceneuron panelist at Anglonordic 2019
Asceneuron will take part in a panel discussion at the Anglonordic conference, on May 9th, 2019 in London.
Asceneuron to present at the European Life Sciences CEO Forum
Our CEO Dirk Beher will be presenter and panellist at the 12th Annual European Life Sciences CEO Forum & Exhibition, February 25th-26th 2019, in Zurich.
Asceneuron appoints Peter Van Vlasselaer as Chairman
Asceneuron appoints Peter Van Vlasselaer as Chairman
Interview of Dirk Beher, CEO & Founder, at the Biotech Showcase
Dirk Beher, CEO & Founder, was interviewed by Mike Ward (Scrip Pharma Intelligence) at the Biotech Showcase in San Francisco last week.
Asceneuron to attend the 37th Annual J.P. Morgan Healthcare Conference
Asceneuron will be taking meetings around the 37th Annual J.P. Morgan Healthcare Conference held on January 7-10, 2018 in San Francisco, CA.